Financial statements Pharmalink
Cash flow statement of Pharmalink
Company age:
Age:
24 y. 4 m. 4 d.
Share capital:
Share capital:
4 000 PLN
Cash inflows of PHARMALINK
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 2 809 986,58 | 6 861 815,94 | 7 216 978,34 | 14 484 255,10 | 7 790 910,57 | 11 211 852,26 |
| Net cash flow from investing activities | -910 454,24 | -2 288 544,36 | -632 952,36 | -10 344 368,33 | 2 408 320,72 | 1 320 323,30 |
| Net cash flow from financial activities | -1 847 833,13 | -3 314 123,67 | -4 483 153,40 | -6 939 114,77 | -9 858 572,43 | -11 676 091,36 |
| Total net cash flow | 51 699,21 | 1 259 147,91 | 2 100 872,58 | -2 799 228,00 | 340 658,86 | 856 084,20 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.